Neglected Diseases

Neglected Diseases PLOS Medicine's Neglected Diseases section began with the launch of the journal in October 2004. Up until February 2008, the section focused on tropical infectious diseases, such as Buruli ulcer, trachoma, and hookworm. A list of the 21 articles published from October 2004 to February 2008 can be found in the Supporting Information section of our February 2008 Editorial. With the launch of PLOS Neglected Tropical Diseases in October 2007, the focus of the Neglected Diseases section of PLOS Medicine shifted from tropical diseases to other health problems that could be considered neglected and that have a significant global burden (such as reproductive and maternal health problems, mental illness in low- and middle-income countries, road traffic injuries, and health problems related to migration and conflict.). Read the February 2008 Editorial for information about the section.

See all article types »

Visceral Leishmaniasis: New Health Tools Are Needed

  • Published: July 26, 2005
  • DOI: 10.1371/journal.pmed.0020211

About the Authors

Corresponding Authors

Competing Interests

The authors are all members of the Leishmaniasis East Africa Platform and are currently engaged in the clinical development of paromomycin for treatment of visceral leishmaniasis. Paromomycin is manufactured as a low-cost generic drug by Grand Pharma, Hyderabad, India, and distributed by International Dispensary Association, Amsterdam, the Netherlands. The Drugs for Neglected Diseases Initiative is a not-for-profit foundation, as is the International Dispensary Association. None of the authors has any financial interest in Grand Pharma.